Amarantus BioScience Holdings Common Stock

Amarantus BioScience Holdings (AMBS) currently reports a common stock of $300K as of March 2023. That compares with $280K in the prior-year period — up 5.9% year over year. Use the charts on this page to explore Amarantus BioScience Holdings's common stock history and peer comparisons.

Amarantus BioScience Holdings's common stock increased from $280K to $300K — a 5.9% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Amarantus BioScience Holdings reported $300K in common stock as of March 2023. That compares with $280K in the prior-year period — up 5.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $300K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amarantus BioScience Holdings, and consider following AMBS for alerts when major investors trade the stock.

Amarantus BioScience Holdings is classified in the Healthcare sector. On common stock, it currently shows $300K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMBS with unrelated industries.